CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study
Abstract
Authors
Rahul Mudumba Xiaofan Liu Jorge J. Nieva John Romley